Label: REDICARE BLOOD CLOTTING- blood clotting spray aerosol, spray
- NDC Code(s): 71105-107-03
- Packager: Redicare LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated August 25, 2025
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purpose
- Uses
-
WARNINGS
For external use only.
Flammable
- Keep away from flame. Contents under pressure.
- Do not puncture or incinerate.
- Do not expose to temperatures above 120°(F)
DO NOT USE
- in eyes or other mucous membranes
- on large portions of the body
- in case of deep or puncture wounds
- on raw surfaces
- on blistered areas
- on animal bites
- on serious burns
DO NOT USE
- in eyes or other mucous membranes
- on large portions of the body
- in case of deep or puncture wounds
- on raw surfaces
- on blistered areas
- on animal bites
- on serious burns
Stop use and ask doctor if:
- Redness, swelling, or irritation occurs
- Infection occurs
- The condition persists or worsens
- Symptoms persist for more than 7 days
- Directions
- Inactive Ingredients
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
REDICARE BLOOD CLOTTING
blood clotting spray aerosol, sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:71105-107 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP) BENZETHONIUM CHLORIDE 170 mg in 85 g LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE 3400 mg in 85 g Inactive Ingredients Ingredient Name Strength 3-(TRIETHOXYSILYL)PROPYLAMINE (UNII: L8S6UBW552) ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS) PROPANE (UNII: T75W9911L6) TRAGACANTH (UNII: 2944357O2O) TALC (UNII: 7SEV7J4R1U) ISOBUTANE (UNII: BXR49TP611) BUTANE (UNII: 6LV4FOR43R) SORBITAN MONOOLEATE (UNII: 06XEA2VD56) KARAYA GUM (UNII: 73W9IQY50Q) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71105-107-03 85 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 10/01/2023 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M003 10/01/2023 Labeler - Redicare LLC (800149346)

